Prospective Study on HIV-related Hodgkin Lymphoma

NCT01468740 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

130

Enrollment

OTHER

Sponsor class

Conditions

HIV-associated Hodgkin Lymphoma

Interventions

DRUG: Doxorubicin
DRUG: Bleomycin
DRUG: Vinblastine
DRUG: Dacarbazine
DRUG: Etoposide
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Procarbazine
DRUG: Prednisone

Sponsor

Harlachinger Krebshilfe e.V.

Collaborators

[object Object]